Soleno Therapeutics (SLNO) Change in Inventory (2015 - 2026)

Soleno Therapeutics' (SLNO) quarterly Change in Inventory came in at $1.8 million in Q1 2026, down 77.17% on a QoQ basis from $8.0 million in Q4 2025.

Soleno Therapeutics (SLNO) Change in Inventory (2015 - 2026) Analysis & Trends

Soleno Therapeutics (SLNO) has 5 years of Change in Inventory data on file, last reported at $1.8 million in Q1 2026.

  • On a quarterly basis, Change in Inventory changed N/A year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $15.9 million, a 13076.28% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, changed N/A from the prior year.
  • Change in Inventory for Q1 2026 stood at $1.8 million, down from $8.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for SLNO reached as high as $8.0 million in Q4 2025 and fell as low as $1.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn 1.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Mar 31, 2026 1.83 Mn
Dec 31, 2025 8.02 Mn
Dec 31, 2025 8.02 Mn
Sep 30, 2025 3.92 Mn
Sep 30, 2025 3.92 Mn
Jun 30, 2025 2.10 Mn
Jun 30, 2025 2.10 Mn
Jun 30, 2017 -32,000.00
Jun 30, 2017 -32,000.00
Mar 31, 2017 195,000.00
Mar 31, 2017 195,000.00
Dec 31, 2016 -42,617.00
Dec 31, 2016 -42,617.00
Sep 30, 2016 -518,000.00
Sep 30, 2016 -518,000.00
Jun 30, 2016 568,000.00
Jun 30, 2016 568,000.00
Mar 31, 2016 102,000.00
Mar 31, 2016 102,000.00